GlassScriptCardiosave Hybrid, Type B Plug
Payments companies reported to CMS as associated with Cardiosave Hybrid, Type B Plug. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cardiosave Hybrid, Type B Plug, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cardiosave Hybrid, Type B Plug
These are the largest totals companies reported as associated with Cardiosave Hybrid, Type B Plug. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ran Lee | Cleveland, OH | Advanced Heart Failure and Transplant Cardiology | $3,354.55 |
| Mohammad Ansari | Lubbock, TX | Interventional Cardiology | $2,220.23 |
| Joseph Thomas | Torrance, CA | Cardiovascular Disease | $2,000.00 |
| Arvind Bhimaraj | Houston, TX | Advanced Heart Failure and Transplant Cardiology | $1,731.63 |
| Marcella Press | Los Angeles, CA | Cardiovascular Disease | $1,600.00 |
| Robin Chand | Los Angeles, CA | Cardiovascular Disease | $1,600.00 |
| Prem Kittusamy | Las Vegas, NV | Cardiovascular Disease | $124.99 |
| Jeffrey Cohen | Washington, DC | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $112.54 |
| Christian Shults | Washington, DC | Surgery | $112.54 |
| Lynn Schnautz | Evansville, IN | Nurse Practitioner | $107.89 |
Prescribed Cardiosave Hybrid, Type B Plug?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.